Sutent

Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Fierce Pharma
Tue, 01/25/22 - 11:28 pm
Deciphera Pharma
Qinlock
stomach cancer
Sutent
ASCO: Merck's Keytruda targets Pfizer's shaky Sutent post-surgery use in kidney cancer
Fierce Pharma
Thu, 06/3/21 - 11:05 pm
ASCO 2021
Merck
Keytruda
kidney cancer
Sutent
Pfizer
The top 10 drugs losing U.S. exclusivity in 2021
Fierce Pharma
Wed, 03/10/21 - 10:59 pm
patents
Lucentis
Bystolic
Vascepa
Narcan
Brovana
Sutent
Saphris
Amitza
Feraheme
ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win
Fierce Pharma
Mon, 09/30/19 - 10:38 am
Chi-Med
surufatinib
Pfizer
Sutent
Novartis
Afinitor
Lutathera
neuroendocrine tumors. ESMO
Merck, Pfizer drug combo extends kidney cancer survival -study
Yahoo/Reuters
Sun, 02/17/19 - 11:57 pm
Merck
Pfizer
kidney cancer
Keytruda
Inlyta
Sutent
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
EP Vantage
Mon, 02/11/19 - 08:24 pm
renal cell carcinoma
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
clinical trials
Sutent
Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
Fierce Pharma
Thu, 10/18/18 - 01:07 pm
Merck
Keytruda
kidney cancer
Pfizer
Inlyta
Sutent
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma
Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales
Fierce Pharma
Thu, 09/21/17 - 10:02 pm
Pfizer
Sutent
kidney cancer
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
What's Pfizer's Excuse for Not Buying Exelixis?
Motley Fool
Wed, 11/30/16 - 09:46 pm
Pfizer
Exelixis
M&A
Cabometyx
kidney cancer
Sutent
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Motley Fool
Mon, 10/17/16 - 11:49 am
Pfizer
Bristol-Myers Squibb
Exelixis
Cabometyx
kidney cancer
Sutent
Opdivo
Exelixis and Pfizer drugs compete in kidney cancer trial
Yahoo/Reuters
Mon, 10/10/16 - 09:15 am
kidney cancer
Exelixis
Pfizer
Sutent
Cabometyx
Pfizer's Sutent comes up big in adjuvant trial, staving off cancer for 6 years-plus
Fierce Pharma
Mon, 10/10/16 - 09:08 am
Pfizer
Sutent
kidney cancer
Here's How Pfizer's Protecting Its Kidney Cancer Drug From New Competitors
Motley Fool
Sun, 07/10/16 - 11:59 am
Pfizer
Sutent
kidney cancer
Exelixis
Bristol-Myers Squibb
Novartis
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
24/7 Wall St
Fri, 05/6/16 - 10:52 am
Pfizer
renal cancer
Sutent
cabozantinib
Exelixis
AstraZeneca
Faslodex
breast cancer
Atossa Genetics
Merck
Zetia
Mylan Labs
What Products Affect Pfizer’s Revenue?
Yahoo/Market Realist
Tue, 03/31/15 - 07:51 am
Pfizer
Lyrica
Prevnar
Enbrel
Celebrex
Lipitor
Viagra
Zyvox
Sutent
Norvasc
Premarin
Pfizer Wins SUTENT® Patent Case In Delaware District Court
Yahoo
Thu, 10/23/14 - 08:34 am
Pfizer
patents
Sutent
Delaware
Pfizer cancer drug Sutent linked to severe skin reactions
CBC News
Mon, 09/9/13 - 09:44 am
Pfizer
Sutent
cancer
Stevens Johnson Syndrome
Pfizer: Renal Cancer Treatment Sutent Sales Forecast
Seeking Alpha
Mon, 06/17/13 - 11:00 am
renal cancer
Pfizer
Sutent

Pages